
Sign up to save your podcasts
Or


Recorded on December 28, 2018
On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biology of the disease, state-of-the-art care, how smoldering myeloma differs from the disease of myeloma, the use of vaccines in cancer treatment, and so much more!
Paul Richardson, MD
By Blood Cancer United4.8
1212 ratings
Recorded on December 28, 2018
On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biology of the disease, state-of-the-art care, how smoldering myeloma differs from the disease of myeloma, the use of vaccines in cancer treatment, and so much more!
Paul Richardson, MD
43,566 Listeners

319 Listeners

3,343 Listeners

56,477 Listeners

46 Listeners

1,147 Listeners

206 Listeners

187 Listeners

22 Listeners

51 Listeners

8 Listeners

19,469 Listeners

48 Listeners

44 Listeners

31 Listeners